MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
about
MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@en
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@nl
type
label
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@en
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@nl
prefLabel
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@en
MALDI mass spectrometry imagin ...... 01L, EGFR-mutated NSCLC cells.
@nl
P2093
P2860
P1433
P1476
MALDI mass spectrometry imagin ...... 901L, EGFR-mutated NSCLC cells
@en
P2093
Akinobu Hamada
Hiroaki Aikawa
Kaname Yamamoto
Masanobu Nishidate
Takehiko Kawanishi
P2860
P2888
P356
10.1038/S41598-017-17211-6
P407
P577
2017-12-01T00:00:00Z